{
  "url": "https://openlegislation.uk/misuse-of-drugs-amendment-england-wales-and-scotland-regulations-2017/regulation-3",
  "json_url": "https://openlegislation.uk/misuse-of-drugs-amendment-england-wales-and-scotland-regulations-2017/regulation-3.json",
  "legislation": "uksi/2017/631",
  "legislation_title": "The Misuse of Drugs (Amendment) (England, Wales and Scotland) Regulations 2017",
  "legislation_url": "https://openlegislation.uk/misuse-of-drugs-amendment-england-wales-and-scotland-regulations-2017",
  "path": "regulation/3",
  "kind": "regulation",
  "number": "3",
  "heading": "Amendment of the Misuse of Drugs Regulations 2001",
  "text": "In paragraph 1(a) of Schedule 1 (which specifies controlled drugs subject to the requirements of regulations 14, 15, 16 , 18, 19, 20, 23, 26 and 27)—\n(a) before “Bufotenine” insert—\n“Adinazolam (1-(8-Chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-1-yl)-N,N-dimethylmethanamine)\nN-Benzyl-ethylphenidate\nBromazolam (8-bromo-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)”;\n(b) after “Cathinone” insert—\n“4’-Chlorodiazepam (7-Chloro-5-(4-chlorophenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one)\nClonazolam (6-(2-Chlorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)”;\n(c) after “Concentrate of poppy-straw” insert—\n“Deschloroetizolam (2-Ethyl-9-methyl-4-phenyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4] diazepine)\n3,4-Dichloroethylphenidate\n3,4-Dichloromethylphenidate (3,4-DCMP)\nDiclazepam (7-Chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one)”;\n(d) after “3-Dimethylheptyl-11-hydroxyhexahydrocannabinol” insert—\n“Ethylnaphthidate\nEthylphenidate”;\n(e) after “Eticyclidine” insert—\n“Etizolam”;\n(f) after “Etryptamine” insert—\n“Flubromazepam (7-Bromo-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one)\nFlubromazolam (8-Bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)\n4-Fluoroethylphenidate\n4-Fluoromethylphenidate\nFonazepam (5-(2-Fluorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one)”;\n(g) after “9-(Hydroxymethyl)-6, 6-dimethyl-3-(2-methyloctan-2-yl)-6a, 7, 10, 10a-tetrahydrobenzo[c]chromen-1-ol” insert—\n“3-Hydroxyphenazepam (7-Bromo-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-2H-1,4-benzodiazepin-2-one)\nIsopropylphenidate (IPP or IPPD)”;\n(h) after “Lysergide and other N-alkyl derivatives of lysergamide” insert—\n“Meclonazepam (5-(2-Chlorophenyl)-3-methyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one)”;\n(i) after “Methcathinone” insert—\n“4-Methylmethylphenidate\nMethylmorphenate\nMethylnaphthidate (HDMP-28)\nMetizolam (4-(2-Chlorophenyl)-2-ethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4] diazepine)\nNifoxipam (5-(2-Fluorophenyl)-3-hydroxy-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2- one)\nNitrazolam (1-Methyl-8-nitro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)\nPropylphenidate”;\n(j) after “Psilocin” insert—\n“Pyrazolam (8-Bromo-1-methyl-6-(2-pyridinyl)-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)”;\n(k) after “3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide (AH-7921)” insert—\n“3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47,700)”.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2017/631/regulation/3",
    "retrieved_at": "2026-10-28T23:10:36.814414+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}